Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;7(6):e38627.
doi: 10.1371/journal.pone.0038627. Epub 2012 Jun 8.

l-Tetrahydropalmatine, an active component of Corydalis yanhusuo W.T. Wang, protects against myocardial ischaemia-reperfusion injury in rats

Affiliations

l-Tetrahydropalmatine, an active component of Corydalis yanhusuo W.T. Wang, protects against myocardial ischaemia-reperfusion injury in rats

Yi Han et al. PLoS One. 2012.

Abstract

l-Tetrahydropalmatine (l-THP) is an active ingredients of Corydalis yanhusuo W.T. Wang, which protects against acute global cerebral ischaemia-reperfusion injury. In this study, we show that l-THP is cardioprotective in myocardial ischaemia-reperfusion injury and examined the mechanism. Rats were treated with l-THP (0, 10, 20, 40 mg/kg b.w.) for 20 min before occlusion of the left anterior descending coronary artery and subjected to myocardial ischaemia-reperfusion (30 min/6 h). Compared with vehicle-treated animals, the infarct area/risk area (IA/RA) of l-THP (20, 40 mg/kg b.w.) treated rats was reduced, whilst l-THP (10 mg/kg b.w.) had no significant effect. Cardiac function was improved in l-THP-treated rats whilst plasma creatine kinase activity declined. Following treatment with l-THP (20 mg/kg b.w.), subunit of phosphatidylinositol 3-kinase p85, serine(473) phosphorylation of Akt and serine(1177) phosphorylation of endothelial NO synthase (eNOS) increased in myocardium, whilst expression of inducible NO synthase (iNOS) decreased. However, the expression of HIF-1α and VEGF were increased in I(30 min)R(6 h), but decreased to normal level in I(30 min)R(24 h), while treatment with l-THP (20 mg/kg b.w.) enhanced the levels of these two genes in I(30 min)R(24 h). Production of NO in myocardium and plasma, activity of myeloperoxidase (MPO) in plasma and the expression of tumour necrosis factor-α (TNF-α) in myocardium were decreased by l-THP. TUNEL assay revealed that l-THP (20 mg/kg b.w.) reduced apoptosis in myocardium. Thus, we show that l-THP activates the PI3K/Akt/eNOS/NO pathway and increases expression of HIF-1α and VEGF, whilst depressing iNOS-derived NO production in myocardium. This effect may decrease the accumulation of inflammatory factors, including TNF-α and MPO, and lessen the extent of apoptosis, therefore contributing to the cardioprotective effects of l-THP in myocardial ischaemia-reperfusion injury.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. The chemical structure of l-THP.
Figure 2
Figure 2. l-THP decreased myocardial infarct size in myocardial I/R (MI/R) rats.
(a) RA (risk area)/LV (left ventricle area) ratio. RA/LV ratio was not changed. (b) IA (infarct area)/RA ratio. Compared with the vehicle group (V), IA/RA ratio was significantly lower in rats that treat with l-THP(M) and l-THP(H), *P<0.05, **P<0.01 vs. vehicle group, n = 6, but l-THP(L) shows no effect. (c) Representative heart sections, compared with vehicle, infarct area was reduced in the heart by l-THP (M) and l-THP (H).
Figure 3
Figure 3. l-THP improves the left ventricular function of myocardial I/R rats.
(a) Typical M-mode echocardiograms (b, c) I/R induced a pronounced reduction in left ventricular ejection fraction (EF) and fractional shortening (FS), both effects being prevented by l-THP. ###P<0.001 vs. sham group (S),*P<0.05,** P<0.01, ***P<0.001vs. vehicle group, n = 6.
Figure 4
Figure 4. l-THP decreased the activity of creatine kinase and myeloperoxidase.
(a) Plasma CK activity of myocardial I/R rats treated with vehicle and l-THP. Plasma CK activity was significantly decreased in rats that treat with l-THP, ###P<0.001 vs. sham group, ***P<0.001 vs. vehicle group, n = 6. (b) Cardiac MPO activity of myocardial I/R rats treated with vehicle and l-THP (M). (c) Plasma MPO activity of myocardial I/R rats treated with vehicle and l-THP (M). Compared with the vehicle group, both cardiac and plasma MPO activity was significantly decreased, ##P<0.01, ###P<0.001 vs. sham group, **P<0.01, ***P<0.001 vs. vehicle group, n = 6.
Figure 5
Figure 5. l-THP decreased level of NO, ONOO and iNOS, regulated expression of p85, eNOS and Akt.
(a) Cardiac NO production concentration of myocardial I/R rats treated with vehicle, and three doses of l-THP. Compared with the vehicle group, NO production concentration was significantly decreased, ###P<0.001 vs. sham group, ***P<0.001 vs. vehicle group, n = 6. (b) The production of NO in plasma in myocardial I/R rats treated with vehicle, and three doses of l-THP. NO concentration was significantly decreased, which compared with the vehicle group, ##P<0.01 vs. sham group, *P<0.05 vs. vehicle group, n = 6. (c) p85 of myocardial I/R rats treated with vehicle and l-THP (M). p85 was significantly increased in l-THP (M)-treated group, #P<0.05 vs. sham group, *P<0.05 vs. vehicle group, n = 5. (d) Serine1177 phosphorylation of eNOS of myocardial I/R rats treated with vehicle and l-THP (M). Serine1177 phosphorylation of eNOS was significantly increased in l-THP (M)-treated group, but total eNOS expression was not increased, ##P<0.05 vs. sham group, **P<0.01 vs. vehicle group, n = 5. (e) Serine473 phosphorylation of Akt of myocardial I/R rats treated with vehicle and l-THP (M). Serine473 phosphorylation of Akt was significantly increased in l-THP (M)-treated group, but total Akt expression was not increased, #P<0.05 vs. sham group, *P<0.05 vs. vehicle group, n = 5. (f) Cardiac ONOO generation, as measured by luminol-enhanced chemiluminescence, in each of the five groups, #P<0.05 vs. sham group, *P<0.05, **P<0.01 vs. vehicle group, n = 6. (g) iNOS expression of myocardial I/R rats treated with vehicle and l-THP (M). iNOS expression was significantly decreased in l-THP (M)-treated group, ###P<0.001 vs. sham group, *P<0.05 vs. vehicle group, n = 5. (h) The mRNA levels of iNOS in myocardial I/R rats treated with vehicle and l-THP (M). iNOS expression was significantly decreased in l-THP (M)-treated group, ###P<0.001 vs. sham group, *P<0.05 vs. vehicle group, n = 6.
Figure 6
Figure 6. l-THP affected the expression of HIF-1 and VEGF.
(a) The mRNA level of HIF-1α in I30 minR6 h. Compared with the sham group, HIF-1α expression significantly increased in vehicle group, ##P<0.01 vs. sham group, *P<0.05 vs. vehicle group, n = 6. (b) The mRNA level of HIF-1α in I30 minR24 h. Compared with the vehicle group, n = 6. (c) The mRNA level of VEGF in I30 minR6 h. Compared with the sham group, VEGF expression significantly increased in vehicle group, #P<0.05 vs. sham group, *P<0.05 vs. vehicle group, n = 6. (d) The mRNA level of VEGF in I30 minR24 h. Compared with the vehicle group, VEGF expression significantly increased in l-THP (M)-treated group, ##P<0.01 vs. sham group, **P<0.01 vs. vehicle group, n = 6.
Figure 7
Figure 7. l-THP decreased cardiac oxidative stress, TNF-α production and myocardial apoptosis.
(a) Representative photomicrographs of DHE-stained cardiac sections in each of the five groups. (b) Cardiac superoxide anion generation measured by lucigenin-enhanced chemiluminescence. Compared with the sham group, superoxide anion production significantly increased in vehicle group, while decreased in l-THP -treated group. #P<0.05 vs. sham group, *P<0.05 vs. vehicle group, n = 6. (c) Cardiac TNF-α concentration of myocardial I/R rats treated with vehicle and l-THP (M). Compared with the vehicle group, cardiac TNF-α concentration was significantly decreased, #P<0.05 vs. sham group, *P<0.05 vs. vehicle group, n = 6. (d) The apoptosis positive cells in myocardial of myocardial I/R rats, as determined by TUNEL assay. (e) Compared with the vehicle group, apoptosis positive cells was significantly increased, ###P<0.001 vs. sham group, **P<0.01 vs. vehicle group, n = 5.

Similar articles

Cited by

References

    1. Griendling KK, Alexander RW. Oxidative stress and cardiovascular disease. Circulation. 1997;96:3264–3265. - PubMed
    1. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985;312:159–163. - PubMed
    1. Dinerman JL, Lowenstein CJ, Snyder SH. Molecular mechanisms of nitric oxide regulation. Potential relevance to cardiovascular disease. Circ Res. 1993;73:217–222. - PubMed
    1. Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 1987;2:1057–1058. - PubMed
    1. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A. 1991;88:4651–4655. - PMC - PubMed

Publication types

MeSH terms

Substances